IDA total vs Senegal: Access to anti-retroviral drugs, female
IDA total
87.1%
in 2024
Senegal
98.0%
in 2024
IDA total rank
4th
Senegal rank
1st
Access to anti-retroviral drugs, female over time
- IDA total
- Senegal
How they compare
Senegal currently reports 98.0% against 87.1% in IDA total, a difference of 10.9%.
That makes Senegal's figure about 1.1 times IDA total's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Senegal ahead.
IDA total ranks 4th and Senegal ranks 1st of 19 groups.
Senegal has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA total | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.5% | 10.6% | 5.1% | Senegal |
| 2010s | 48.9% | 62.8% | 13.9% | Senegal |
| 2020s | 80.9% | 95.0% | 14.1% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, IDA total or Senegal?
- Senegal, at 98.0% against 87.1% in IDA total as of 2024.
- What is the difference in access to anti-retroviral drugs, female between IDA total and Senegal?
- 10.9%, with Senegal ahead.
- How many years of comparable data are there for IDA total and Senegal?
- 25 years are reported by both, from 2000 to 2024.
- How do IDA total and Senegal rank globally for access to anti-retroviral drugs, female?
- IDA total ranks 4th and Senegal ranks 1st of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.